These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8740293)

  • 41. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The child with short stature.
    Oberfield SE; Levine LS
    N Y State J Med; 1986 Jan; 86(1):15-21. PubMed ID: 3081841
    [No Abstract]   [Full Text] [Related]  

  • 43. Multiple hormone resistance in short children born with intrauterine growth retardation?
    Chatelain PG; Nicolino M; Claris O; Salle B; Chaussain J
    Horm Res; 1998; 49 Suppl 2():20-2. PubMed ID: 9730667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation?
    Shalet SM
    Arch Dis Child; 1992 May; 67(5):662. PubMed ID: 1599310
    [No Abstract]   [Full Text] [Related]  

  • 45. Growth hormone treatment of short stature due to intrauterine growth retardation.
    Stanhope R
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):665-6. PubMed ID: 11155086
    [No Abstract]   [Full Text] [Related]  

  • 46. The newborn baby with intrauterine growth retardation (IUGR): medical treatment and choice of the follow-up.
    Papageorgiou A
    Pediatr Med Chir; 2002; 24(6):456-7. PubMed ID: 12610925
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of the condition of newborn infants whose mothers were subjected to treatment for intrauterine fetal retardation during pregnancy].
    Gajewska E; Jabłońska T; Fuchs B; Rudnicka M; Orlik-Adamska S; Gabryś M
    Ginekol Pol; 1987 Feb; 58(2):76-80. PubMed ID: 3609839
    [No Abstract]   [Full Text] [Related]  

  • 48. Bone growth and metabolic studies of premature infants treated with human growth hormone.
    Chiumello G; Vaccari A; Sereni F
    Pediatrics; 1965 Dec; 36(6):836-42. PubMed ID: 5846825
    [No Abstract]   [Full Text] [Related]  

  • 49. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome.
    Dessì A; Atzori L; Noto A; Visser GH; Gazzolo D; Zanardo V; Barberini L; Puddu M; Ottonello G; Atzei A; De Magistris A; Lussu M; Murgia F; Fanos V
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():35-9. PubMed ID: 21767100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
    de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated growth hormone secretory rate in premature infants: deconvolution analysis of pulsatile growth hormone secretion in the neonate.
    Wright NM; Northington FJ; Miller JD; Veldhuis JD; Rogol AD
    Pediatr Res; 1992 Sep; 32(3):286-90. PubMed ID: 1408463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes.
    Kesavan K; Devaskar SU
    Pediatr Clin North Am; 2019 Apr; 66(2):403-423. PubMed ID: 30819345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of preterm infants with intrauterine growth restriction.
    Fang S
    Early Hum Dev; 2005 Nov; 81(11):889-900. PubMed ID: 16266791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Intra-uterine growth retardation: guidelines for clinical practice--Short text].
    French College of Gynecologists and Obstetricians
    J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):1018-25. PubMed ID: 24216306
    [No Abstract]   [Full Text] [Related]  

  • 55. Retarded fetal growth patterns and early neonatal mortality in a Mexico City population.
    Balcazar H; Haas JD
    Bull Pan Am Health Organ; 1991; 25(1):55-63. PubMed ID: 2054553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Short stature. Etiology and possible therapy].
    Butenandt O
    Monatsschr Kinderheilkd; 1993 Dec; 141(12):956-68. PubMed ID: 8114780
    [No Abstract]   [Full Text] [Related]  

  • 57. Growth hormone treatment does not alter lower limb asymmetry in children with Russell-Silver syndrome.
    Rizzo V; Traggiai C; Stanhope R
    Horm Res; 2001; 56(3-4):114-6. PubMed ID: 11847473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth hormone treatment in patients with intrauterine growth retardation.
    Lanes R
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1345-6. PubMed ID: 10720090
    [No Abstract]   [Full Text] [Related]  

  • 59. [Blood glucose in newborn infants, at term premature infants and infants with fetal growth retardation].
    Rokicki W
    Ginekol Pol; 1983 Feb; 54(2):99-103. PubMed ID: 6683695
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intrauterine growth retardation, its consequences in infancy, in the child and long term].
    Salle BL; Chatelain P; Nicolino M; Claris O
    Bull Acad Natl Med; 2001; 185(7):1271-6; discussion 1276-8. PubMed ID: 11975323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.